Results 71 to 80 of about 22,618 (258)

Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration [PDF]

open access: yes, 2012
Hyperprolactinemia is the most common cause of hypogonadotropic anovulation and is one of the leading causes of infertility in women aged 25-34. Hyperprolactinemia has been proposed to block ovulation through inhibition of GnRH release.
Alain Caraty   +10 more
core   +4 more sources

Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

open access: yesIatreia, 2016
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic
López-Clavijo, Carlos Alberto   +3 more
doaj   +1 more source

The Clinical and Metabolic Profiles in Menstrual Changes Among Reproductive‐Aged Women Post‐COVID‐19

open access: yesMedComm, Volume 6, Issue 6, June 2025.
This study recruited 253 Chinese women of reproductive age and post‐COVID‐19 infection. Serious factors, including age and perceived stress, contribute to menstrual changes while general medical condition was the only independent risk factor. Notable metabolic change existed in group with any menstruation changes, with special sex hormone: T decreased ...
Wei Wang   +13 more
wiley   +1 more source

CHARACTERISTICS OF PITUITARY-OPVARIAN-ADRENAL AXIS IN ADOLESCENT GIRLS WITH HYPERPROLACTINEMIA OF VARIOUS GENESIS

open access: yesActa Biomedica Scientifica, 2012
The article presents the results of examination of 97 adolescent girls (mean age 14,96 ± 0,26 years) with hyperprolactinemia (PRL levels above 700 IU/ml): 30 adolescent girls with pituitary microprolactinoma (mean age 14,7 ± 3.2 years) and 67 adolescent ...
A. V. Labygina   +7 more
doaj  

Advances in the treatment of prolactinomas [PDF]

open access: yes, 2006
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of ...
1997 Data on file   +627 more
core   +1 more source

Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue S3, Page 31-47, June 2025.
Abstract Metformin, a synthetic biguanide, is widely used to manage type 2 diabetes, and is commonly prescribed in polycystic ovary syndrome (PCOS) to address insulin resistance and associated metabolic and reproductive disturbances. PCOS is characterised by hormonal imbalances such as hyperandrogenism and anovulation, metabolic abnormalities including
Saeede Saadati   +5 more
wiley   +1 more source

Development of Hyperprolactinemia Induced by the Addition of Bupropion to Venlafaxine XR Treatment

open access: yesBezmiâlem Science, 2018
Hyperprolactinemia is characterized by abnormally increased serum prolactin levels. Menstrual irregularities and hyperprolactinemia can be caused by a variety of medical conditions as well as due to the use of some psychopharmacological drugs, namely ...
Alperen KILIÇ   +3 more
doaj   +1 more source

Long‐Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data

open access: yesEarly Intervention in Psychiatry, Volume 19, Issue 6, June 2025.
ABSTRACT Introduction The primary objective was to analyse the prescribing and discontinuation rates of long‐acting injectable (LAI) antipsychotics among child and adolescent populations. The secondary objective was to assess if racial/ethnic differences existed between LAI antipsychotics and discontinuation rates.
Taylor M. Ward   +6 more
wiley   +1 more source

Macroprolactinemia: a New Cause of Hyperprolactinemia

open access: yesJournal of Pharmacological Sciences, 2003
Hyperprolactinemia is not only seen in pregnancy but also in several pathological conditions such as prolactin (PRL) secreting pituitary adenoma (prolactinoma), intracranial tumors compressing the pituitary stalk or hypothalamus, and PRL stimulative ...
Naoki Hattori
doaj  

Erectile dysfunction in cardiovascular patients: A prospective study of the eNOS gene T‐786C, G894T, and INTRON variable number of the tandem repeat functional interaction

open access: yesAndrology, Volume 13, Issue 4, Page 794-803, May 2025.
Abstract Background Cardiovascular disease induces erectile dysfunction modulated by endothelial nitric oxide synthase enzyme and an impaired ejection fraction that restricts penis vascular congestion. However, the mechanisms regulating endothelial dysfunction are not understood.
Ana Segura   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy